Fundraising Fox
🦊/Companies
Sign in

Miracor Medical

8 known investors

Find your way into Miracor Medical

Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.

HealthtechMedical Devices

Investors · 8

Delta PartnersDublin · $108K – $3.2M
Ming capitalShenzhen
Quest for Growthreported · 2 sourcesLeuven

Also in the syndicate · 5

EarlybirdNoshaqSFPI-FPIMSRIWYonghua

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
MIRACOR MEDICAL UK LIMITED
Company number
13351395
Status
Dissolved
Company type
Private limited company
Incorporated
22 Apr 2021
Dissolved
24 Dec 2024
Registered office
Fairbourne Drive, Atterbury, Milton Keynes, Buckinghamshire, MK10 9RG
Nature of business (SIC)
26600 — Manufacture of irradiation, electromedical and electrotherapeutic equipment
Accounts
last made up to 30 Apr 2023
Confirmation statement
last made up to 21 Apr 2024

Current officers

  • Olivier Delporte — director, appointed 22 Apr 2021
  • Gillian Margaret Glennon — director, appointed 17 May 2021
  • Bertrand Grimmonpre — director, appointed 22 Apr 2021

Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Studybusinesswire.com · Aug 2022Miracor Medical raises €24M Series E capital round from Yonghua, Earlybird, Noshaq, Quest for Growth, SFPI-FPIM, SRIW | Nordic 9nordic9.com · Sep 2020Miracor Medical Raises €24M in Funding - FinSMEsfinsmes.com · Sep 2020Miracor Medical Systems GmbH Receives Additional Funding In Series-C Closing To Expand Clinical And Commercial Activities With The PiCSO Impulse System - BioSpacebiospace.com · Oct 2016Miracor Medical Systems receives additional funding to accelerate clinical validation and commercialization of its PICSO® Impulse System | Radcliffe Cardiologyradcliffecardiology.com · Feb 2015Miracor raises $10M in Series B | Fierce Biotechfiercebiotech.com · Sep 2011

Frequently asked questions

What does Miracor Medical do?
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
Who are Miracor Medical's investors?
Miracor Medical's investors include Delta Partners, Ming capital, Quest for Growth.